一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Acta Anaesthesiologica Scandinavica >>article
Acta Anaesthesiologica Scandinavica

Acta Anaesthesiologica Scandinavica

IF: 1.89
Download PDF

Pharmacokinetic implications for the clinical use of atropine, scopolamine and glycopyrrolate.

Published:1 February 1988 DOI: 10.1111/j.1399-6576.1988.tb02691.x PMID: 3279717
J Kanto, U Klotz

Abstract

Several specific and sensitive new methods for determining atropine and its metabolites in biological fluids have increased the possibility to characterise the pharmacokinetic properties of this antimuscarinic agent. Following i.v. injection, atropine disappears very quickly from the circulation, resembling its fast onset of action. Age, but not sex, appears to have a clear effect on its kinetics, explaining at least partly the higher sensitivity of very young and very old patients to this anticholinergic agent. Following i.m. or oral atropine administration, typical anticholinergic effects coincide quite well with the absorption rate of the drug, indicating that the premedication should be given about 1 and 2 h before induction of anaesthesia. A sufficient absorption after rectal administration offers an alternative treatment, especially in children. Differing from its placental transfer, atropine has a delayed and incomplete lumbar cerebrospinal fluid penetration, indicating a fundamental difference between these two biological membranes. Oropharyngeally administered atropine has a very variable absorption, but inhaled or intratracheally given drug has produced interesting new results, e.g. pulmonary atropine administration appears to have clinical significance in special situations, such as cardiac arrest and organophosphate poisoning (military personnel). Depending on the method used, different data on the metabolism and excretion for atropine have been reported and therefore further studies are needed in this respect. The pharmacokinetics of scopolamine and glycopyrrolate and their relation to clinical response are poorly understood.

Substances (3)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Glycopyrrolate 596-51-0 C19H28BrNO3- 495 suppliers $9.00-$1500.00
Atropine 51-55-8 C17H23NO3 305 suppliers $22.40-$1697.85
Scopolamine 51-34-3 C17H21NO4 210 suppliers $50.00-$40480.00

Similar articles

IF:0

Clinical use of hydroxyethyl starch and serious adverse effects: Need for awareness amongst the medical fraternity

Medical Journal Armed Forces India Surg Vice Adm Sushil Kumar AVSM, NM,etc Published: 1 July 2014
IF:4.3

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

ACS Applied Electronic Materials Noemi Lois, Evie Gardner,etc Published: 14 July 2020
民乐县| 邳州市| 泽普县| 柞水县| 天等县| 钟山县| 武强县| 洪泽县| 土默特左旗| 铜山县| 锡林浩特市| 乐陵市| 罗甸县| 尉氏县| 鸡西市| 高雄市| 呼图壁县| 文安县| 黑水县| 肥城市| 德安县| 宣武区| 苗栗县| 博客| 宁波市| 广河县| 崇州市| 乌兰察布市| 绥德县| 霍林郭勒市| 凯里市| 石景山区| 水城县| 轮台县| 济源市| 北碚区| 聂拉木县| 洛宁县| 新密市| 巴中市| 桂平市|